Status:
UNKNOWN
Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation
Lead Sponsor:
Deutsches Herzzentrum Muenchen
Conditions:
Coronary Artery Disease
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The investigators hypothesize that reducing the duration of clopidogrel therapy from 6 months to 6 weeks after DES implantation is associated with improved clinical outcomes in patients on ASA and an ...
Detailed Description
The introduction of drug-eluting stents (DES) was associated not only with a widening of the indication for percutaneous coronary intervention (PCI) but also with longer antithrombotic therapy duratio...
Eligibility Criteria
Inclusion
- Key
- Patients with an indication for oral anticoagulation and a DES implantation.
- Informed, written consent by the patient or her/his legally-authorized representative for participation in the study.
- Key
Exclusion
- Age ≤18 years
- Previous stent thrombosis
- DES in left main
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
614 Patients enrolled
Trial Details
Trial ID
NCT00776633
Start Date
September 1 2008
End Date
September 1 2014
Last Update
August 30 2016
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Denmark, 8200
2
Deutsches Herzzentrum München
Munich, Germany, 80636
3
1. Medizinische Klinik, Klinikum rechts der Isar
München, Germany, 81675